Artiva Biotherapeutics, Inc. Operating Lease, Expense
Artiva Biotherapeutics, Inc. (ARTV) reported Operating Lease, Expense of $1.00 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-11-12
- Artiva Biotherapeutics, Inc. operating lease, expense for the quarter ending 2024-09-30 was $1.00M, a 5.02% decline year-over-year.
- Artiva Biotherapeutics, Inc. operating lease, expense for the quarter ending 2024-06-30 was $1.02M, a 7.14% increase year-over-year.
- Artiva Biotherapeutics, Inc. operating lease, expense for the quarter ending 2023-09-30 was $1.06M.
- Artiva Biotherapeutics, Inc. operating lease, expense for the quarter ending 2023-06-30 was $952.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $1.00M 10-Q · filed 2024-11-12 | $2.02M derived: sum of 2 quarters · filed 2024-11-12 | $3.04M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.02M 10-Q · filed 2024-08-29 | $2.04M 10-Q · filed 2024-08-29 | |
| 2023-09-30 | $1.06M 10-Q · filed 2024-11-12 | $2.01M derived: sum of 2 quarters · filed 2024-11-12 | $3.09M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $952.00K 10-Q · filed 2024-08-29 | $2.04M 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |